Skip to content

Clinical trials

Respiratory Tract Neoplasms trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Tract Neoplasms Country / region: South Korea Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20102
20173
20192
20201
20212
20222
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Active, not recruiting3
Recruiting3
Terminated3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company3
Revolution Medicines, Inc.3
Blueprint Medicines Corporation2
Daiichi Sankyo Co., Ltd.2
Hoffmann-La Roche2
AVEO Pharmaceuticals, Inc.1
ArriVent BioPharma, Inc.1
Turning Point Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung15
Respiratory Tract Neoplasms15
Neoplasms14
Lung Neoplasms13
Lung Diseases12
Neoplasms by Site12
Respiratory Tract Diseases12
Bronchial Neoplasms11
Thoracic Neoplasms11
Carcinoma, Bronchogenic8

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.